Switch theme
Sign up to access all valuation multiples
Futura Medical PLC is engaged in the development and commercialization of sexual health products. Its product Eroxon is a treatment for erectile dysfunction. Geographically, the company derives a majority of its revenue from the United Kingdom and the European Union.
2001
12
LTM Revenue $20.0M
LTM EBITDA $5.4M
$33.7M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Futura Medical has a last 12-month revenue of $20.0M and a last 12-month EBITDA of $5.4M.
In the most recent fiscal year, Futura Medical achieved revenue of $4.0M and an EBITDA of -$8.8M.
Futura Medical expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Futura Medical valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $4.0M | $17.9M | XXX | XXX | XXX |
| Gross Profit | n/a | n/a | XXX | XXX | XXX |
| Gross Margin | NaN% | NaN% | XXX | XXX | XXX |
| EBITDA | -$8.8M | $3.3M | XXX | XXX | XXX |
| EBITDA Margin | -220% | 18% | XXX | XXX | XXX |
| Net Profit | -$6.4M | -$7.5M | XXX | XXX | XXX |
| Net Margin | -160% | -42% | XXX | XXX | XXX |
| Net Debt | n/a | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Futura Medical's stock price is GBP 0 (or $0).
Futura Medical has current market cap of GBP 30.1M (or $38.7M), and EV of GBP 26.2M (or $33.7M).
See Futura Medical trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $33.7M | $38.7M | XXX | XXX | XXX | XXX | $0.01 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Futura Medical has market cap of $38.7M and EV of $33.7M.
Futura Medical's trades at 1.7x LTM EV/Revenue multiple, and 6.2x LTM EBITDA.
Analysts estimate Futura Medical's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Futura Medical and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $33.7M | XXX | XXX | XXX |
| EV/Revenue | 1.9x | XXX | XXX | XXX |
| EV/EBITDA | 10.2x | XXX | XXX | XXX |
| P/E | 100.3x | XXX | XXX | XXX |
| P/E/Growth | n/a | XXX | XXX | XXX |
| EV/FCF | -9.7x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpFutura Medical's NTM/LTM revenue growth is 31%
Futura Medical's revenue per employee for the last fiscal year averaged $0.3M, while opex per employee averaged $0.9M for the same period.
Over next 12 months, Futura Medical's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Futura Medical's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Futura Medical and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 348% | XXX | XXX | XXX | XXX |
| EBITDA Margin | 18% | XXX | XXX | XXX | XXX |
| EBITDA Growth | -137% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | 49% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.3M | XXX | XXX | XXX | XXX |
| Opex per Employee | $0.9M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 216% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | 66% | XXX | XXX | XXX | XXX |
| Opex to Revenue | 282% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Julphar | XXX | XXX | XXX | XXX | XXX | XXX |
| Benevolent AI | XXX | XXX | XXX | XXX | XXX | XXX |
| Galapagos | XXX | XXX | XXX | XXX | XXX | XXX |
| Pharming | XXX | XXX | XXX | XXX | XXX | XXX |
| Vivoryon Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Futura Medical acquired XXX companies to date.
Last acquisition by Futura Medical was XXXXXXXX, XXXXX XXXXX XXXXXX . Futura Medical acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Futura Medical founded? | Futura Medical was founded in 2001. |
| Where is Futura Medical headquartered? | Futura Medical is headquartered in United Kingdom of Great Britain and Northern Ireland. |
| How many employees does Futura Medical have? | As of today, Futura Medical has 12 employees. |
| Who is the CEO of Futura Medical? | Futura Medical's CEO is Mr. James Henry Barder. |
| Is Futura Medical publicy listed? | Yes, Futura Medical is a public company listed on LON. |
| What is the stock symbol of Futura Medical? | Futura Medical trades under FUM ticker. |
| When did Futura Medical go public? | Futura Medical went public in 2003. |
| Who are competitors of Futura Medical? | Similar companies to Futura Medical include e.g. Julphar, Benevolent AI, Galapagos, Pharming. |
| What is the current market cap of Futura Medical? | Futura Medical's current market cap is $38.7M |
| What is the current revenue of Futura Medical? | Futura Medical's last 12-month revenue is $20.0M. |
| What is the current EBITDA of Futura Medical? | Futura Medical's last 12-month EBITDA is $5.4M. |
| What is the current EV/Revenue multiple of Futura Medical? | Current revenue multiple of Futura Medical is 1.7x. |
| What is the current EV/EBITDA multiple of Futura Medical? | Current EBITDA multiple of Futura Medical is 6.2x. |
| What is the current revenue growth of Futura Medical? | Futura Medical revenue growth between 2023 and 2024 was 348%. |
| Is Futura Medical profitable? | Yes, Futura Medical is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
